are compound tirzepatide safe Compounded to Treat Diabetes What Is Compounded Tirzepatide?
Description
The study found that use of GLP-1 agonists (semaglutides) for weight loss compared with the use of other products, was associated with an increased risk of gastrointestinal adverse events including pancreatitis, gastroparesis, and bowel obstruction

Abstract Glucagon-like peptide-1 (GLP-1) promotes insulin secretion from pancreatic -cells in a glucose dependent manner

writing-review and editing, Meiling Hao
The studies found that patients who take GLP-1 drugs were more likely to develop the condition

While IGF-1 has insulin-agonistic actions and has been used for treatment of severe insulin resistance, IGF-1 reduction with the GH antagonist pegvisomant improves glycemic control in acromegalic patients with diabetes or impaired glucose tolerance despite elevated GH (35, 36)

More if you can
